Chrousos Phaedra (CIK 1774518) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy VNDA (41,600 shares), Buy VNDA (59,225 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Vanda Pharmaceuticals Inc. (VNDA) | Director | Buy | 41,600 | $0 |
| 2025-06-09 | Vanda Pharmaceuticals Inc. (VNDA) | Director | Buy | 59,225 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08